Robert D. Steiner, MD is Executive Director, Marshfield Clinic Research Foundation, Chief Science Officer Marshfield Clinic, and Executive Associate Director, University of Wisconsin Institute for Clinical and Translational Research (ICTR).  He is also Visiting Professor, University of Wisconsin School of Medicine and Public Health.  Steiner was formerly (prior to 4/2013) Credit Unions for Kids Professor of Pediatric Research, Professor of Pediatrics and Molecular & Medical Genetics, and Vice Chair for Research in Pediatrics at Doernbecher Children’s Hospital and the Institute for Developmental Disabilities, Oregon Health & Science University (OHSU) in Portland, Oregon.  Steiner earned his BS with Honors from the University of Wisconsin, followed by MD from the University of Wisconsin School of Medicine.  He subsequently completed residency in pediatrics at Cincinnati Children’s Hospital Medical Center and fellowship in medical genetics at the University of Washington and Seattle Children’s Hospital. Dr. Steiner is board certified in pediatrics, clinical genetics, and clinical biochemical genetics.

Dr. Steiner is an active clinician in the field of medical genetics, with specific interests in inherited metabolic diseases, cholesterol disorders, metabolic bone diseases, and newborn screening.  He has been listed in Best Doctors in America 2009-13 Inclusive, and Portland’s Top Doctors, Portland Monthly Magazine, 2012.  In addition, he is an accomplished researcher, having served as the Principal Investigator for more than a dozen clinical trials and clinical research studies on Smith-Lemli-Opitz Syndrome (SLOS), Osteogenesis Imperfecta, Phenylketonura, Lysosomal Storage Diseases, and others.  His research on SLOS and related disorders is funded by the National Institutes of Health, in part by an award from the NIH Rare Disease Clinical Research Network (RDCRN).  Steiner has authored over 125 peer-reviewed original research articles, and more than 70 letters, reviews, book sections, and book chapters, on genetic diseases and related topics.  He currently serves as an editorial board member of the Journal of Inherited Metabolic Disease and New Horizons in Translational Medicine, and is presently the Deputy Editor for Genetics in Medicine. 

Dr. Steiner is a member of several professional societies, including the American Society of Human Genetics, American College of Medical Genetics, Society for Inherited Metabolic Disorders, and the Society for the Study of Inborn Errors of Metabolism.  He’s an elected member of the Society for Pediatric Research.  Dr. Steiner has had numerous appointments on national committees and advisory boards including serving as Chair of the American College of Medical Genetics working group on Pompe disease, as a Standing Committee member of the Newborn Screening Translational Research Network, and as a member of the American College of Medical Genetics Therapeutics Committee.  He is an active supporter of several patient advocacy groups including service on the SLOS Foundation Medical Advisory Board, and Batten Disease Spport and Research Association Medical/Scientific Advisory Board.  Steiner was an elected member of the executive committee for the Section on Genetics and Birth Defects of the American Academy of Pediatrics.  Recently, he was elected a member of the American College of Medical Genetics Board of Directors, term starting in 2013.  He teaches in the SIMD North American Metabolic Academy (NAMA).  Finally, he was a member of the Institute of Medicine (IOM) Committee that published recommendations on Accelerating Rare Diseases Research and Orphan Product Development.

View this presentation here.